MIRA INFORM REPORT
|
Report No. : |
322444 |
|
Report Date : |
16.05.2015 |
IDENTIFICATION DETAILS
|
Name : |
ZHEJIANG DONGJIAN PHARMACEUTICAL CO., LTD. |
|
|
|
|
Registered Office : |
Room 401, No. 10 Second Xiyuan Road, Sandun Town, Xihu District
Hangzhou, Zhejiang Province 310030 Pr |
|
|
|
|
Country : |
China |
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Date of Incorporation : |
09.06.2011 |
|
|
|
|
Com. Reg. No.: |
330100000152818 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Subject is engaged in selling pharmaceutical products. |
|
|
|
|
No. of Employee : |
10 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CHINA ECONOMIC OVERVIEW
Since the
late 1970s China has moved from a closed, centrally planned system to a more
market-oriented one that plays a major global role - in 2010 China became the world's
largest exporter. Reforms began with the phasing out of collectivized
agriculture, and expanded to include the gradual liberalization of prices,
fiscal decentralization, increased autonomy for state enterprises, growth of
the private sector, development of stock markets and a modern banking system,
and opening to foreign trade and investment. China has implemented reforms in a
gradualist fashion. In recent years, China has renewed its support for
state-owned enterprises in sectors considered important to "economic
security," explicitly looking to foster globally competitive industries.
After keeping its currency tightly linked to the US dollar for years, in July
2005 China moved to an exchange rate system that references a basket of currencies.
From mid 2005 to late 2008 cumulative appreciation of the renminbi against the
US dollar was more than 20%, but the exchange rate remained virtually pegged to
the dollar from the onset of the global financial crisis until June 2010, when
Beijing allowed resumption of a gradual appreciation. In 2014 the People’s Bank
of China (PBOC) doubled the daily trading band within which the RMB is
permitted to fluctuate. The restructuring of the economy and resulting
efficiency gains have contributed to a more than tenfold increase in GDP since
1978. Measured on a purchasing power parity (PPP) basis that adjusts for price
differences, China in 2014 stood as the largest economy in the world,
surpassing the US that year... Still, per capita income is below the world
average.
The
Chinese government faces numerous economic challenges, including: (a) reducing
its high domestic savings rate and correspondingly low domestic consumption;
(b) facilitating higher-wage job opportunities for the aspiring middle class,
including rural migrants and increasing numbers of college graduates; (c)
reducing corruption and other economic crimes; and (d) containing environmental
damage and social strife related to the economy's rapid transformation.
Economic development has progressed further in coastal provinces than in the
interior, and by 2011 more than 250 million migrant workers and their
dependents had relocated to urban areas to find work. One consequence of
population control policy is that China is now one of the most rapidly aging
countries in the world. Deterioration in the environment - notably air
pollution, soil erosion, and the steady fall of the water table, especially in
the North - is another long-term problem. China continues to lose arable land
because of erosion and economic development. The Chinese government is seeking
to add energy production capacity from sources other than coal and oil,
focusing on nuclear and alternative energy development. Several factors are
converging to slow China's growth, including debt overhang from its
credit-fueled stimulus program, industrial overcapacity, inefficient allocation
of capital by state-owned banks, and the slow recovery of China's trading
partners. The government's 12th Five-Year Plan, adopted in March 2011 and
reiterated at the Communist Party's "Third Plenum" meeting in
November 2013, emphasizes continued economic reforms and the need to increase
domestic consumption in order to make the economy less dependent in the future
on fixed investments, exports, and heavy industry. However, China has made only
marginal progress toward these rebalancing goals. The new government of
President XI Jinping has signaled a greater willingness to undertake reforms
that focus on China's long-term economic health, including giving the market a
more decisive role in allocating resources. In 2014 China agreed to begin
limiting carbon dioxide emissions by 2030. China implemented several economic
reforms in 2014, including legislation allowing local governments to issue
bonds, further opening several state-owned enterprises to private investment,
loosening the one-child policy, passing harsher pollution fines, and cutting
administrative red tape.
|
Source
: CIA |
company
name and address
ZHEJIANG DONGJIAN PHARMACEUTICAL CO., LTD.
ROOM 401, NO. 10 second XIYUAN ROAD, SANDUN TOWN, XIHU DISTRICT
HANGZHOU, ZHEJIANG PROVINCE 310030 PR CHINA
TEL: 86 (0) 571-28995991/28995979
FAX: 86 (0) 571-28995971
EXECUTIVE
SUMMARY
Date of Registration : JUNe 9, 2011
REGISTRATION NO. : 330100000152818
LEGAL FORM : Limited Liability Company
REGISTERED CAPITAL : CNY 10,000,000
staff : 10
BUSINESS CATEGORY : TRADING
Revenue : CNY 44,580,000 (AS OF DEC. 31, 2014)
EQUITIES : CNY 7,380,000 (AS OF DEC. 31, 2014)
WEBSITE : N/A
E-MAIL : N/A
PAYMENT : AVERAGE
MARKET CONDITION : AVERAGE
FINANCIAL CONDITION : FAIR
OPERATIONAL TREND : Ordinary
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE : CNY 6.20 = USD 1 AS
ADOPTED ABBREVIATIONS (AS FOLLOWS)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
OPERATIONAL
TREND & GENERAL REPUTATION
This section aims at indicating the relative positions of SC in respect of
its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not yet be determined
Not yet be determined
LEGAL
STATUS & HISTORY
SC was established
as a limited liabilities company of PRC with State Administration of Industry
& Commerce (SAIC) under registration No.: 330100000152818 on June 9, 2011.
SC’s Organization Code Certificate No.:
57439730-X
SC’s Tax No.: 33010057439730X
SC’s registered capital: CNY 10,000,000
SC’s paid-in capital: CNY 10,000,000
Registration Change Record:-
No significant changes of SC have been noted
in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief executives are
as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Ying Zhengshang |
50 |
|
Shen Yanyang |
40 |
|
Gu Xiaofeng |
10 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative, Chairman, and
General Manager |
Ying Zhengshang |
|
Supervisor |
Sun Chuanjiang |
RECENT
DEVELOPMENT
No recent development was found during our checks at present.
SHAREHOLDER
CHART & BACKGROUND
Name %
of Shareholding
Ying Zhengshang 50
Shen Yanyang 40
Gu Xiaofeng 10
MANAGEMENT
Ying Zhengshang, Legal Representative, Chairman and General
Manager
-----------------------------------------------------------------------------------------------------------
Ø
Gender: M
Ø Qualification:
University
Ø Working experience
(s):
At present, working in SC as legal
representative, chairman and general manager
Supervisor
---------------
Sun Chuanjiang
BUSINESS
OPERATION
SC’s registered business scope includes technical development, technical
transfer, technical advisory and technical service of medical intermediates;
importing and exporting commodities; wholesaling and retailing chemical raw
materials and products (excluding hazardous chemicals and precursor chemicals),
electronic products, garments and fabric; other legitimate items.
SC is mainly engaged in selling
pharmaceutical products.
SC’s products mainly
include:
D-phemylalanine
2-(7-Methoxy-1-naphthyl)
ethylamine hydrochloride
7-Methoxy-1-naphthylacetonitrile
L-ornithine
L-aspartate
L-Leucine
SC sources the products 100% from domestic market, mainly Guangdong. SC sells 40% of its products in domestic market, and 60% to overseas market, mainly Mid East, Southeast Asia, etc.
The buying terms
of SC include Check, T/T and Credit of 30-60 days. The payment terms of SC
include T/T, L/C and Credit of 30-60 days.
Staff & Office:
--------------------------
SC is known
to have approx. 10 staff at
present.
SC rents an area
as its operating office, but the detailed information is unknown.
RELATED
COMPANY
Hangzhou Oriental Pharm-Tech Co., Ltd.
------------------------------------
Date
of Registration:
Registration
No.: 330108000031880
Legal
representative: Wu Shanshan
Hangzhou
Roundcare Industrial Co., Ltd.
------------------------------
Date
of Registration:
Registration
No.: 330100000141676
Legal
representative: Shen Yanyang
Hangzhou
Bihe Network Technology Co., Ltd.
------------------------------------
Date
of Registration:
Registration
No.: 330105000069879
Legal
representative: Shen Yanyang
PAYMENT
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not
provide any name of trade/service suppliers and we have no other sources to
conduct the enquiry at present.
Delinquent payment record: None in our
database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
BANKING
Basic Bank:
China Minsheng
Bank
AC#: N/a
FINANCIALS
Balance Sheet
|
Unit: CNY’000 |
As
of Dec. 31, 2014 |
|
6,240 |
|
|
Notes receivable |
0 |
|
Accounts
receivable |
8,650 |
|
Other receivable |
14,160 |
|
Inventory |
250 |
|
Prepaid expenses |
90 |
|
Other current
assets |
0 |
|
|
------------------ |
|
Current assets |
29,390 |
|
Fixed assets |
160 |
|
Long-term prepaid
expenses |
0 |
|
Deferred income
tax assets |
0 |
|
Other
non-current assets |
0 |
|
|
------------------ |
|
Total assets |
29,550 |
|
|
============= |
|
Short-term loans |
9,940 |
|
Notes payable |
0 |
|
Accounts payable |
5,630 |
|
Taxes payable |
30 |
|
Advances from
clients |
6,570 |
|
Other payable |
0 |
|
Other current
liabilities |
0 |
|
|
------------------ |
|
Current
liabilities |
22,170 |
|
Non-current
liabilities |
0 |
|
|
------------------ |
|
Total
liabilities |
22,170 |
|
Equities |
7,380 |
|
|
------------------ |
|
Total
liabilities & equities |
29,550 |
|
|
============= |
Income Statement
|
Unit: CNY’000 |
As of Dec. 31,
2014 |
|
Revenue |
44,580 |
|
Cost of sales |
40,800 |
|
Taxes and surcharges |
70 |
|
Sales expense |
1,400 |
|
Management expense |
1,970 |
|
Finance expense |
1,330 |
|
Profit before
tax |
-930 |
|
Less: profit tax |
0 |
|
-930 |
Important Ratios
=============
|
|
As
of Dec. 31, 2014 |
|
*Current ratio |
1.33 |
|
*Quick ratio |
1.31 |
|
*Liabilities to
assets |
0.75 |
|
*Net profit
margin (%) |
-2.09 |
|
*Return on
total assets (%) |
-3.15 |
|
*Inventory /
Revenue ×365 |
3 days |
|
*Accounts
receivable/ Revenue ×365 |
71 days |
|
*Revenue/Total
assets |
1.51 |
|
*Cost of sales
/ Revenue |
0.92 |
FINANCIAL
COMMENTS
PROFITABILITY:
FAIR
l The revenue of SC
appears average in its line.
l SC’s net profit
margin is fair.
l SC’s return on
total assets is fair.
l
SC’s cost of sales is average, comparing with its
revenue.
LIQUIDITY: AVERAGE
l
The current ratio of SC is maintained in a normal
level.
l
SC’s quick ratio is maintained in a fairly good
level.
l
The inventory of SC appears small.
l
The accounts receivable of SC appears large.
l
The short-term loans of SC appear large.
l
SC’s revenue is in an average level, comparing with
the size of its total assets.
LEVERAGE: FAIR
l
The debt ratio of SC is fairly high.
l
The risk for SC to go bankrupt is average.
Overall financial
condition of the SC: Fair.
CONCLUSIONS
SC is considered small-sized in its line with fair financial conditions.
The large amount of accounts receivable and short-term loans may be a threat to
SC’s financial condition.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.58 |
|
|
1 |
Rs.100.30 |
|
Euro |
1 |
Rs.72.38 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.